KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Gross Profit (2016 - 2026)

AbbVie has reported Gross Profit over the past 14 years, most recently at $12.1 billion for Q4 2025.

  • Quarterly Gross Profit rose 12.7% to $12.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.0 billion through Dec 2025, up 8.94% year-over-year, with the annual reading at $43.0 billion for FY2025, 8.94% up from the prior year.
  • Gross Profit was $12.1 billion for Q4 2025 at AbbVie, up from $10.5 billion in the prior quarter.
  • Over five years, Gross Profit peaked at $12.1 billion in Q4 2025 and troughed at $7.4 billion in Q3 2023.
  • The 5-year median for Gross Profit is $9.9 billion (2021), against an average of $9.8 billion.
  • Year-over-year, Gross Profit surged 40.54% in 2021 and then dropped 23.98% in 2023.
  • A 5-year view of Gross Profit shows it stood at $10.6 billion in 2021, then grew by 3.64% to $11.0 billion in 2022, then decreased by 21.5% to $8.6 billion in 2023, then grew by 24.53% to $10.7 billion in 2024, then grew by 12.7% to $12.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Gross Profit are $12.1 billion (Q4 2025), $10.5 billion (Q3 2025), and $11.1 billion (Q2 2025).